Release Date: April 10, 2023
Expiration Date: April 10, 2024
Activity Overview
This brief online educational activity is designed to place key updates from recent studies in the management of acute myeloid leukemia, with particular focus on emerging targeted therapy options. The multimedia format includes an audio interview with Ghayas Issa, MD, who provides a summary of the key findings from these studies and places them into the context of clinical practice.
Target Audience
These educational activities are directed toward medical oncologists, hematologists, nurses, and other oncology health care professionals.
Learning Objectives
Upon successful completion of this activity, you should be better prepared to:
- Outline current and emerging diagnostic strategies for predictive and prognostic biomarkers that best inform treatment decision-making in patients with MDS and leukemias
- Evaluate recent safety and efficacy data of agents/combinations investigated in patients with MDS and leukemias
- Assess recent evidence from clinical trials evaluating approved and emerging therapies within the context of evolving treatment paradigms for patients with MDS and leukemias
GET STARTED WITH THIS PROGRAM:
Register now to gain access to this program.
Create AccountAlready Registered? Login Here
